Ecology and toxicity in marine sponges

Author(s): Green G

Abstract

An investigation of the ecology of toxicity in marine sponges from different latitudes on the North American continent was made. Results indicated that toxicity in sponges increased with decreasing latitude. Three of the 34 species (9%) of sponges from San Juan Island, Washington, USA (48°N), were toxic to fishes. Nine of the 44 species (20%) of sponges from Santa Catalina Island, California, USA (33°N), were toxic. Seven of the 11 species (64%) of sponges from Zihuatanejo Bay, Guerrero, México (17°N), were toxic. Twenty-seven of the 36 species (75%) of sponges from La Blanquilla, Veracruz, México (19°N), were toxic. Most of these toxic sponges are openly exposed to fishes. The most common exposed sponges proved to be highly toxic to fishes. Force-feeding experiments conducted with wrasses demonstrated the effectiveness of the toxin of sponges. A hypothesis is proposed which explains the relationship between species diversity of fishes and sponge toxicity with latitude.

Similar Articles

Producing drugs from marine sponges

Author(s): Belarbi el H, Contreras Gómez A, Chisti Y, García Camacho F, Molina Grima E

Marine sponges as pharmacy

Author(s): Sipkema D, Franssen MC, Osinga R, Tramper J, Wijffels RH

Anti-biofilm compounds derived from marine sponges

Author(s): Stowe SD, Richards JJ, Tucker AT, Thompson R, Melander C, et al.

Biogeography of sponge chemical ecology: comparisons of tropical and temperate defenses

Author(s): Becerro MA, Thacker RW, Turon X, Uriz MJ, Paul VJ

Porifera: Sponges

Author(s): Lavrov D

Drug development from marine natural products

Author(s): Molinski TF, Dalisay DS, Lievens SL, Saludes JP

Marine natural products as anticancer drugs

Author(s): Simmons TL, Andrianasolo E, McPhail K, Flatt P, Gerwick WH

Approaches to identify, clone, and express symbiont bioactive metabolite genes

Author(s): Hildebrand M, Waggoner LE, Lim GE, Sharp KH, Ridley CP, et al.

The value of natural products to future pharmaceutical discovery

Author(s): Baker DD, Chu M, Oza U, Rajgarhia V

Antiviral lead compounds from marine sponges

Author(s): Sagar S, Kaur M, Minneman KP

Current status on natural products with antitumor activity from Brazilian marine sponges

Author(s): Frota MJ, Silva RB, Mothes B, Henriques AT, Moreira JC

Marine natural products

Author(s): Blunt JW, Copp BR, Keyzers RA, Munro MH, Prinsep MR

Bioactive indole derivatives from the South Pacific marine sponges Rhopaloeides odorabile and Hyrtios sp

Author(s): Longeon A, Copp BR, Quévrain E, Roué M, Kientz B, et al.

Isolation of steroidal glycosides from the Caribbean sponge Pandaros acanthifolium

Author(s): Berrué F, McCulloch MW, Boland P, Hart S, Harper MK, et al.

The odyssey of marine pharmaceuticals: a current pipeline perspective

Author(s): Mayer AM, Glaser KB, Cuevas C, Jacobs RS, Kem W, et al.

Monanchocidin: a new apoptosis-inducing polycyclic guanidine alkaloid from the marine sponge Monanchora pulchra

Author(s): Guzii AG, Makarieva TN, Denisenko VA, Dmitrenok PS, Kuzmich AS, et al.

The marine compound spongistatin 1 targets pancreatic tumor progression and metastasis

Author(s): Rothmeier AS, Schneiders UM, Wiedmann RM, Ischenko I, Bruns CJ, et al.

New lysophosphatidylcholines and monoglycerides from the marine sponge Stelletta sp

Author(s): Zhao Q, Mansoor TA, Hong J, Lee CO, Im KS, et al.